Deals Update

Article preview from Medtech Insight- October 01, 2010

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Deals Update

Article preview from Medtech Insight- October 01, 2010

Mergers & Acquisitions

3M Co. & Arizant Inc.

To expand its infection prevention offerings, 3M Co. is paying $810mm in cash to acquire Arizant Inc., which develops surgical patient warming systems.

 

Amedica Corp. & US Spine Inc.

Amedica Corp. (develops spinal and orthopedic implants using silicon nitride (SiN) ceramic technologies) is acquiring closely held spinal implant developer US Spine Inc. for an undisclosed amount.

 

Asthmatx Inc. & Boston Scientific Corp.

Boston Scientific Corp. has agreed to buy closely held Asthmatx Inc. (asthma device) for $193.5mm in cash up front and up to $250mm in revenue-based earn-outs through 2019.

 

Fresenius Medical Care AG (a division of Fresenius SE) & Gambro AB

Gambro AB (kidney devices) has sold its global peritoneal dialysis (PD) business to Fresenius Medical Care AG (products and treatments for chronic kidney disease).

 

Genzyme Genetics (a division of Genzyme Corp.) & Laboratory Corp. of America Holdings

Laboratory Corp. of America Holdings is acquiring esoteric testing specialist Genzyme Genetics for $925mm in cash. The company offers services spanning maternal serum screening, prenatal and postnatal diagnostics, carrier screening, and clinical trials central lab testing.

 

Singapore Volition Pte. Ltd. & ValiBIO SA (a division of ValiRx PLC)

ValiRx PLC has divested its ValiBIO SA diagnostics division to fellow cancer test developer Singapore Volition Pte. Ltd. for $1mm, of which $400k will be paid in cash (in four equal installments) and the remainder in Volition shares.

Continued...

To read this article in its entirety, Purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Medtech Insight Newsletter.

About Medtech Insight

Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices.

Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512